跳至主要内容
临床试验/NCT02114736
NCT02114736Unknown4 期

A Randomized Controlled Trial of Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke

University Hospital of Mont-Godinne1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
20
试验地点
1
主要终点
Ashworth scale at the rectus femoris

研究概览

简要总结

Stiff knee gait is defined as the lack of knee flexion in the swing phase of gait. Stiff knee gait is a frequent condition among stroke patients leading to reduce gait speed and increase energy cost. In association with neuro-rehabilitation, botulinum toxin A injections in the rectus femoris is recommended. However, the botulinum toxin A effect is transient necessitating repeated injections.

The aim of this study is to compare the benefit of the rectus femoris tenotomy in comparison with botulinum toxin A injections according to the 3 domains of the International Classification of Functioning Disability and Health of the World Health Organisation

详细描述

INTRODUCTION

Stroke is the third cause of death and the leading cause of handicap among industrialized countries. Spasticity and co-contraction of the rectus femoris muscle following stroke is responsible for a lack of knee flexion in the swing phase of gait named stiff knee gait.

The rectus femoris spasticity is usually treated by oral medications, physical therapy and botulinum toxin A injections (1,2). As botulinum toxin A has a transient effect, injections must be repeated supporting to promote a permanent surgical treatment such as the rectus femoris tenotomy (3). However, no study has evaluate neither compare the effect of the rectus femoris tenotomy on gait and on the 3 domains of the International Classification of Functioning Disability and Health .

OBJECTIVE

To compare the effect of the rectus femoris tenotomy and of the botulinum toxin A injections for stiff knee gait after stroke according to the 3 domains of the International Classification of Functioning Disability and Health

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • stroke lasting for more than 6 months
  • stiff knee gait
  • rectus femoris spasticity (> Ashworth 2)
  • transient improvement with previous botulinum toxine A injection in the rectus femoris
  • stiff knee gait improved after rectus femoris diagnostic motor nere block
  • able to walk on treadmill

排除标准

  • pregnant women
  • botulinum toxin A injections in the rectus femoris < 6 months
  • previous surgery for stiff knee gait

研究组 & 干预措施

Rectus femoris tenotomy

Experimental

Surgical release of the proximal tendon of the rectus femoris

干预措施: Tenotomy of the proximal rectus femoris tendon (Procedure)

Botulinum toxin in the rectus femoris muscle

Active Comparator

Botulinum toxin (200U Botox) injection in the rectus femoris muscle

干预措施: Botulinum Toxin injection in the rectus femoris muscle (Drug)

结局指标

主要结局

Ashworth scale at the rectus femoris

时间窗: 6 months

Spasticity assessment scale

次要结局

  • Stroke impairment assessment set (SIAS(6 months)
  • Tardieu scale(6 months)
  • MRC (Medical research Council) scale(6 months)
  • Isometric muscle strenght assessment(6 months)
  • 10 meter walking test(6 months)
  • Instrumented gait analysis(6 months)
  • ABILOCO scale(6 months)
  • EQ-5D-5L scale(6 months)

研究者

发起方
University Hospital of Mont-Godinne
申办方类型
Other
责任方
Principal Investigator
主要研究者

Deltombe Thierry

Professeur Clinique

University Hospital of Mont-Godinne

研究点 (1)

Loading locations...

相似试验